Can I read Fendo 14 1188969 on EtoBox?

Fendo 14 1188969 by Wen Liang is a document available to read on EtoBox.

What is Fendo 14 1188969 about?

This systematic review evaluates the effects of denosumab and romosozumab on bone mineral density (BMD) and turnover markers in osteoporosis patients. The analysis of six studies indicates that romosozumab demonstrates superior efficacy in improving BMD and bone turnover markers compared to denosumab, particularly after 6 to 12 months of treatment. Both treatments are effective, but romosozumab shows greater benefits in the long term.

Author

Wen Liang

Language

EN